PLEASANTON, Calif., Jan. 28, 2021 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the fourth quarter and full year ended December 31, 2020 after market close on Wednesday, February 17, 2021. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook.
News
10x Genomics to Present at the 38th Annual J.P. Morgan Healthcare Conference
PLEASANTON, Calif., Jan. 07, 2020 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. […]
News
10x Genomics to Participate in the Morgan Stanley 2020 Healthcare Conference
PLEASANTON, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) — 10x Genomics (Nasdaq: TXG) today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare Conference. […]
News
10x Genomics to Present at the 39th Annual J.P. Morgan Healthcare Conference
PLEASANTON, Calif., Dec. 23, 2020 (GLOBE NEWSWIRE) — 10x Genomics (Nasdaq: TXG) today announced the company will be participating in the upcoming 39th Annual J.P. Morgan Virtual Healthcare Conference. […]
